Compare Enveric Biosciences Inc (ENVB) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Upwork Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.80M), while Upwork Inc trades at $8.66 (market cap $1.07B). The key difference: Upwork Inc is far larger — about 157.4× Enveric Biosciences Inc's market cap, and Enveric Biosciences Inc is more actively traded (64,867 versus 2,574,130). Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Upwork Inc for 38 Days on average.
| ENVB | UPWK | |
|---|---|---|
Market Cap | $6.80M | $1.07B |
Volume | 64,867 | 2,574,130 |
Sector | Health | Industrials |
52-Week High | $10.80 | $22.11 |
52-Week Low | $1.27 | $7.84 |
Typical Hold Time | 14 Days | 38 Days |
Enterprise Value | -$1.49M | $833.01M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.45, down 3.01% on the day, with a bearish technical signal driven by moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten quarterly EPS expectations. Recent positive developments include a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in investor conferences.
The outlook is mixed; analyst consensus is 75% buy with strong earnings beats, but high negative ROE/ROA and operational cash burn pose significant risks. Investment opportunity hinges on successful drug development, while key risks include funding needs and clinical trial outcomes.
Upwork trades at $8.40, up 0.48% on the day, with a bearish technical signal and neutral oscillators. The company reported Q2 2026 EPS of $0.41, beating expectations, but revenue guidance disappointed, causing a recent sell-off. Financials show strong gross margins of 77.21% and a P/E of 10.99, indicating potential undervaluation. Recent news includes insider selling and a securities fraud investigation, adding to investor caution.
The outlook is mixed: solid profitability and low valuation offer upside, but AI disruption risks and weak guidance pose challenges. Analysts are split with a $9.64 price target, suggesting moderate upside from current levels if execution improves and sentiment recovers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
